Biolife Solutions (BLFS) Return on Invested Capital (2019 - 2026)

Biolife Solutions (BLFS) has reported Return on Invested Capital for 8 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
• Return on Invested Capital fell to 0.01% in Q1 2026 per BLFS's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.29% in Q2 2023 and bottomed at 0.67% in Q3 2022.
• Historically, Return on Invested Capital has averaged 0.06% across 5 years, with a median of 0.0% in 2025.
• Annual changes were most pronounced in 2022 — Return on Invested Capital sank 71 bps — and 2023, when it surged 86 bps.
• Biolife Solutions' Return on Invested Capital stood at 0.0% in 2022, then tumbled by 1582 bps to 0.05% in 2023, then surged by 91 bps to 0.0% in 2024, then declined by 2 bps to 0.0% in 2025, then declined by 20 bps to 0.01% in 2026.
• Business Quant data shows BLFS's Return on Invested Capital at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.